跳至主要内容
临床试验/CTRI/2024/12/077960
CTRI/2024/12/077960尚未招募不适用

Evaluating The Effects Of Ginkgo Biloba In The Management Of Attention Deficit Hyperactivity Disorder In Children An Exploratory Study

Bakson Medical college & hospital1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年12月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
35
试验地点
1
主要终点
The outcome of the study will be assessed through changes in Conners parent rating scale

研究概览

简要总结

This is a single-blind clinical study using the predefined homoeopathic medicine (Ginkgo Biloba) in decimal potency in the management of ADHD, the primary outcome is to assess the efficacy of ginkgo biloba by using Conner’s parent rating scale at baseline, 3 months, 6 months.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 17.00 Year(s)(—)
性别
All

入选标准

  • Clinicaly diagnosed cases of ADHD.
  • Childrens from 3 to 17 years of age of both the sexes male and female.
  • Participants who are taking different types of therapies.

排除标准

  • Participants suffering with severe systemic illness or any immuno-compromised conditions, severe psychiatric illness, substance abuse and endocrine disorders.
  • Participants taking any form of treatment since last 3 months.

结局指标

主要结局

The outcome of the study will be assessed through changes in Conners parent rating scale

时间窗: scale will be assessed at baseline 3 months 6 months

in ADHD childrens before and after our medicine

时间窗: scale will be assessed at baseline 3 months 6 months

次要结局

未报告次要终点

研究者

发起方
Bakson Medical college & hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Vrishti Baghel

Bakson Homoeopathic Medical College And Hospital

研究点 (1)

Loading locations...

相似试验